BioNTech SE announced on Monday that its total revenue in the fourth quarter of its fiscal 2024 plunged by 24.4% year-over-year to land at €1.2 billion, topping analysts' estimates. The company reported a net profit of €259.5 million, down from a net profit of €457.9 million observed in the same period...
A Dusseldorf court ruled in favor of Moderna in a patent dispute against Biontech and Pfizer on Tuesday, ordering them to disclose profits and compensate for unauthorized use of patented mRNA technology.Moderna claimed the companies copied innovations it had developed between 2010...
Shares of vaccine makers, including Moderna, Pfizer, and BioNTech, dipped Tuesday after the Senate Finance Committee advanced Robert F. Kennedy Jr.'s nomination for Health and Human Services secretary.The 14-13 party-line vote moved the controversial pick to the Senate floor. Kennedy, known...
BioNTech SE announced on Monday that its total revenue in the third quarter of fiscal 2024 climbed by 28% year-over-year to land at €1.2 billion. The company reported a net profit of €198.1 million, up from a net profit of €160.6 million observed in the same period of 20232, while the diluted...
BioNTech SE announced on Monday its total revenue in the second quarter dipped by 23% on a yearly basis to €128.7 million. The company saw a net loss of €807 million, down from a net loss of €190 million in the second quarter of 2023, while the diluted loss per share came in at €3.36, compared to...
BioNTech SE said on Monday its total revenues in the first quarter of 2024 amounted to €187.6 million, plunging 85% from the €1.3 billion reported in the first trimester of 2023. The company attributed the drop to lower commercial revenues from the supply and sales of its COVID-19 vaccines...
BioNTech SE announced on Wednesday that its total revenue in the fourth quarter of fiscal 2023 plummeted 65% year-over-year to land at €1.48 billion. The company saw a net profit of €458 million, down from a net profit of €2.28 billion in the same period of 2022, while the diluted earnings per share...
BioNTech, the company known for developing the COVID-19 vaccine with Pfizer, expects revenues in 2024 to be around €3 billion, it said in a statement on Tuesday. The forecast is part of the company's strategy to expand its oncology business, with several product launches planned in the coming...
BioNTech SE announced on Monday its total revenue in the third quarter plummeted 74% on a yearly basis to €895 million. The company saw a net profit of €161 million, down from a net income of €1.8 billion in the second third of 2022, while the diluted loss per share came in at €0.67, compared...
The Nobel Assembly at the Karolinska Institute announced on Monday Katalin Kariko and Drew Weissman as the winners of the 2023 Nobel Prize in Physiology and Medicine.
The scientists won the award for "their discoveries in the field of nucleic acid base modification, which allowed the...
This website uses cookies to ensure you get the best experience. Our Terms of Use and Data Protection Policy explain the data we collect, why we collect them, and how we may share them.
